Biochemical and clinical profiles of 52 Tunisian patients affected by Zellweger syndrome

Lazarow, 1995, Disorders of peroxisome biogenesis, 2287 Wilson, 1986, Zellweger syndrome: diagnostic assays, syndrome delineation, and potential therapy, Am J Med Genet, 24, 69, 10.1002/ajmg.1320240109 Singh, 1984, Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy, Proc Natl Acad Sci U S A, 81, 4203, 10.1073/pnas.81.13.4203 Goldfischer, 1973, Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome, Science, 182, 62, 10.1126/science.182.4107.62 Kelley, 1983, Review: the cerebrohepatorenal syndrome of Zellweger, morphologic and metabolic aspects, Am J Med Genet, 16, 503, 10.1002/ajmg.1320160409 Govaerts, 1982, Cerebro-hepato-renal syndrome of Zellweger: clinical symptoms and relevant laboratory findings in 16 patients, Eur J Pediatr, 139, 125, 10.1007/BF00441495 Grayer, 2005, Recognition of Zellweger syndrome in infancy, Adv Neonatal Care, 5, 5, 10.1016/j.adnc.2004.10.007 Theil, 1992, Clinical recognition of patients affected by a peroxisomal disorder: a retrospective study in 40 patients, Eur J Pediatr, 151, 117, 10.1007/BF01958955 Shimozawa, 2003, Genetic heterogeneity of peroxisome biogenesis disorders among Japanese patients: evidence for a founder haplotype for the most common PEX10 gene mutation, Am J Med Genet A, 120A, 40, 10.1002/ajmg.a.20030 Vreken, 1998, Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography–electron impact mass spectrometry, J Chromatogr B Biomed Sci Appl, 713, 281, 10.1016/S0378-4347(98)00186-8 Wanders, 2005, Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders, Clin Genet, 67, 107, 10.1111/j.1399-0004.2004.00329.x Moser, 1991, Measurement of saturated very long chain fatty acid in plasma, 177 Nasrallah, 2015, X-linked adrenoleukodystrophy. The Tunisian experience, Clin Lab, 61, 1531, 10.7754/Clin.Lab.2015.150318 Nasrallah, 2015, Clinical and Biochemical profile of Tyrosinemia type 1 in Tunisia, Clin Lab, 61, 487, 10.7754/Clin.Lab.2014.141009 Levesque, 2012, A founder mutation in the PEX6 gene is responsible for increased incidence of Zellweger syndrome in a French Canadian population, BMC Med Genet, 13, 72, 10.1186/1471-2350-13-72 Gould, 2001, The peroxisome biogenesis disorders, 3181 Komatsuzaki, 2015, First Japanese case of Zellweger syndrome with a mutation in PEX14, Pediatr Int, 57, 1189, 10.1111/ped.12713 Zung, 1990, Occurrence of cerebrohepatorenal (Zellweger) syndrome in the Karaite community in Israel: a genetic hypothesis, Isr J Med Sci, 26, 570 Ben Halim, 2016, Differential impact of consanguineous marriages on autosomal recessive diseases in Tunisia, Am J Hum Biol, 28, 171, 10.1002/ajhb.22764 Hadj-Taieb, 2012, Aminoacidopathies and organic acidurias in Tunisia: a retrospective survey over 23 years, Tunis Med, 90, 258 Al-Essa, 1999, Zellweger syndrome in Saudi Arabia and its distinct features, Clin Pediatr (Phila), 38, 77, 10.1177/000992289903800203 Baumgartner, 1998, Clinical approach to inherited peroxisomal disorders: a series of 27 patients, Ann Neurol, 44, 720, 10.1002/ana.410440505 Dacremont, 1995, Measurement of very long chain fatty acids, phytanic and pristanic acid in plasma and cultured fibroblasts by gas chromatography, J Inherit Metab Dis, 18, S76, 10.1007/BF00711430 Poll-The, 2012, Clinical diagnosis, biochemical findings and MRI spectrum of peroxisomal disorders, Biochim Biophys Acta, 1822, 1421, 10.1016/j.bbadis.2012.03.011 Whitcomb, 1988, Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro, J Clin Invest, 81, 185, 10.1172/JCI113292 Govaerts, 1989, Further analysis of the disturbed adrenocortical function in the cerebro-hepato-renal syndrome of Zellweger, J Inherit Metab Dis, 12, 423, 10.1007/BF01802037 Van Den Branden, 1993, Altered adrenocortical response under the influence of experimentally increased serum very long chain fatty acids in rats, Pathol Res Pract, 189, 558, 10.1016/S0344-0338(11)80366-3 Berendse, 2014, The high prevalence of primary adrenal insufficiency in Zellweger spectrum disorders, Orphanet J Rare Dis, 9, 133, 10.1186/s13023-014-0133-5 Berendse, 2016, Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood, J Inherit Metab Dis, 39, 93, 10.1007/s10545-015-9880-2 Steinberg, 2004, The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum, Mol Genet Metab, 83, 252, 10.1016/j.ymgme.2004.08.008 Ebberink, 2011, Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder, Hum Mutat, 32, 59, 10.1002/humu.21388 Furuki, 2006, Mutations in the peroxin Pex26p responsible for peroxisome biogenesis disorders of complementation group 8 impair its stability, peroxisomal localization, and interaction with the Pex1p × Pex6p complex, J Biol Chem, 281, 1317, 10.1074/jbc.M510044200 Tamura, 2006, Dynamic and functional assembly of the AAA peroxins, Pex1p and Pex6p, and their membrane receptor Pex26p, J Biol Chem, 281, 27693, 10.1074/jbc.M605159200